HIGHLIGHTS
- who: Yi-Kai Wang from the DivisionUniversity, Taipei, Taiwan, have published the research work: Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol, in the Journal: Scientific Reports Scientific Reports
- what: The study was approved by the Institutional Review Board of Taipei Veterans General Hospital and was conducted in accordance with the principles of Declaration of Helsinki and the International Conference on Harmonization for Good Clinical Practice.
- how: The results showed that compared with non-SOF DAAs SOF-based DAAs were associated with significant increases in TC and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.